Rotterdam, Netherlands

Franklin Gerardus Grosveld

This inventor holds 19 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Antibody Production. Top assignees: Erasmus University Medical Center, Medical Research Council, Erasmus University Medical Centre. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franklin Gerardus Grosveld. Retrieved from https://idiyas.com/inventor/franklin-gerardus-grosveld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 159(Granted Patents)


Location History:

  • London, GB (1996 - 1999)
  • 3065 NH Rotterdam, NL (1999)
  • Rotterdam, NL (1998 - 2024)

Company Filing History:


Years Active: 1996-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antibodies
Heavy Chain Only Antibodies
Transgenic Mammals
Gene Expression
Binding Molecules
Neurodegenerative Disease
Integration Site Independent
Soluble Antibodies
Expression Systems
DNA Molecules
Targeting Complexes
19 patents (USPTO):Explore Patents

Title: Franklin Gerardus Grosveld: Innovations in Antibody Production

Introduction

Franklin Gerardus Grosveld is a notable inventor based in Rotterdam, Netherlands, and has made significant contributions to the field of antibody production through his innovative research. With an impressive portfolio of 18 patents, Grosveld's work reflects a deep understanding of genetic engineering and its applications in immunology.

Latest Patents

Among his latest patents, Grosveld focuses on groundbreaking methods for antibody production. One of his patents involves a transgenic non-human mammal that contains heterologous lambda light chain gene locus and/or kappa light chain gene locus. This innovative approach allows for the rearrangement of immunoglobulin heavy and light chain genes, which are expressed in B-cells upon antigen challenge. In addition, he has developed a method for producing heavy chain only antibodies in transgenic mammals, which involves a mammal containing a heterologous heavy chain gene locus, capable of generating soluble heavy chain only antibodies and antigen-binding fragments following immunization.

Career Highlights

Franklin Gerardus Grosveld has collaborated with reputable institutions such as Erasmus University Medical Center and the Medical Research Council throughout his career. His work at these institutions has positioned him at the forefront of research in biotechnology and genetic engineering.

Collaborations

Grosveld has worked alongside esteemed colleagues, including Roger Kingdon Craig and Richard Wilhelm Janssens. Their combined expertise has undoubtedly propelled significant advancements in their research endeavors, particularly in the fields of molecular biology and immunology.

Conclusion

Franklin Gerardus Grosveld's innovations in antibody production exemplify the intersection of genetic engineering and therapeutic advancement. With a total of 18 patents, his contributions continue to influence the scientific community and pave the way for future developments in antibody therapies. His work is a testament to the impact of dedicated research and collaboration in addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…